Moderna says it will begin developing a vaccine for seasonal flu

Moderna noted that vaccines generally reduce people's risk of getting influenza by 40% to 60% compared with people who aren't inoculated.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.